<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian Pacing Electrophysiol J</journal-id><journal-id journal-id-type="publisher-id">Indian Pacing Electrophysiol J</journal-id><journal-title-group><journal-title>Indian Pacing and Electrophysiology Journal</journal-title></journal-title-group><issn pub-type="epub">0972-6292</issn><publisher><publisher-name>Indian Pacing and Electrophysiology Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16943929</article-id><article-id pub-id-type="pmc">1502066</article-id><article-id pub-id-type="publisher-id">ipej040156-00</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Issues in QT interval measurement</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lanjewar</surname><given-names>Pallavi</given-names></name><xref ref-type="aff" rid="aff1">*</xref></contrib><contrib contrib-type="author"><name><surname>Pathak</surname><given-names>Vaishali</given-names></name><xref ref-type="aff" rid="aff1">*</xref></contrib><contrib contrib-type="author"><name><surname>Lokhandwala</surname><given-names>Yash</given-names></name><xref ref-type="aff" rid="aff2">†</xref></contrib></contrib-group><aff id="aff1"><label>*</label>Quintiles ECG Services, Mumbai</aff><aff id="aff2"><label>†</label>Arrhythmia Associates, Mumbai</aff><author-notes><corresp>Address for correspondence: Dr. Yash Lokhandwala, MD,DM, Arrhythmia Associates, Mumbai. E-mail: <email>dryash2004@yahoo.co.in</email></corresp></author-notes><pub-date pub-type="collection"><season>Oct-Dec</season><year>2004</year></pub-date><pub-date pub-type="epub"><day>1</day><month>10</month><year>2004</year></pub-date><volume>4</volume><issue>4</issue><fpage>156</fpage><lpage>161</lpage><permissions><copyright-statement>Copyright: © 2004 Lanjewar et al.</copyright-statement><copyright-year>2004</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><offsets xml_i="2522" xml_f="2724" txt_i="11" txt_f="213">The QT interval, apart from clinical implications is crucial for safety assessment of new drugs under development. A QTc prolongation of even 10 msec in a study group is a warning signal for a new drug.</offsets></p><p><offsets xml_i="2731" xml_f="3038" txt_i="214" txt_f="521">There are various issues involved in the measurement of the QT interval especially regarding the ending of the T wave and different morphological pattern of T-U complex. The other issue is significant spontaneous variability in the QT interval, resulting in spurious QT prolongation and unnecessary concern.</offsets></p><p><offsets xml_i="3045" xml_f="3436" txt_i="522" txt_f="913">To minimize all these confounding factors, all clinical trials for assessing QT interval prolongation should be randomized and double blinded with appropriate control groups including placebo. ECG measurements should be done by  trained readers with electronic calipers at  ECG core Lab. ECGs should be compared  with multiple baseline values with multiple, time-matched on-treatment values.</offsets></p></abstract></article-meta></front><body><p><offsets xml_i="3483" xml_f="3647" txt_i="921" txt_f="1085"> The QT interval represents the time required for completion of both ventricular depolarization and repolarisation and has been a parameter of particular interest [</offsets><xref ref-type="bibr" rid="R1"><offsets xml_i="3678" xml_f="3679" txt_i="1085" txt_f="1086">1</offsets></xref><offsets xml_i="3686" xml_f="4034" txt_i="1086" txt_f="1434">]. Certain drugs have the ability to delay cardiac repolarization manifested as QT interval prolongation. This creates an electrophysiological environment that favors the development of cardiac arrhythmias, most important of which is torsades de pointes, but possibly other ventricular arrhythmias as well. This can result in sudden cardiac death [</offsets><xref ref-type="bibr" rid="R2"><offsets xml_i="4065" xml_f="4066" txt_i="1434" txt_f="1435">2</offsets></xref><offsets xml_i="4073" xml_f="4074" txt_i="1435" txt_f="1436">]</offsets></p><p><offsets xml_i="4081" xml_f="4901" txt_i="1437" txt_f="2257">Recently it has become evident that a variety of drugs induce QT interval prolongation. Besides the many antiarrhythmic drugs that are well known to widen the QT interval as their main pharmacological effects, non- antiarrhythmic drugs such as antipsychotic,  antiallergic, antibiotics and gastroenterologic agents have been shown to induce QT prolongation as a side effect. A careful assessment of QT interval prolongation is often required before novel drugs are approved by regulatory authorities. For accurate evaluation of the QT interval, the fact that the QT interval varies in RR interval dependent manner must be taken into account. Clinically, several QT-correcting formulas, such as Bazett’s, Fredericia’s, etc. have been used to evaluate QT prolongation considering changes in the length of the RR interval [</offsets><xref ref-type="bibr" rid="R3"><offsets xml_i="4932" xml_f="4933" txt_i="2257" txt_f="2258">3</offsets></xref><offsets xml_i="4940" xml_f="4942" txt_i="2258" txt_f="2260">].</offsets></p><p><offsets xml_i="4949" xml_f="5238" txt_i="2261" txt_f="2550"> The QT interval and corrected QTc are defined below:

            QT interval represents the duration of ventricular depolarization and subsequent repolarization, beginning at the initiation of the Q wave of the QRS complex and ending where the T wave returns to the isoelectric baseline.</offsets></p><sec sec-type="" id="s1"><title><offsets xml_i="5274" xml_f="5288" txt_i="2551" txt_f="2565">Choice of Lead</offsets></title><p><offsets xml_i="5299" xml_f="5413" txt_i="2566" txt_f="2680">By convention Lead II is used for QT measurements. An alternative lead is used only when lead II was not adequate.</offsets></p></sec><sec sec-type="" id="s2"><title><offsets xml_i="5455" xml_f="5481" txt_i="2682" txt_f="2708">Measurement of QT interval</offsets></title><p><offsets xml_i="5492" xml_f="5843" txt_i="2709" txt_f="3060"> Often the end of the T wave is not clear. In such cases the end of the T-wave can be extrapolated by using the Tangent method. The start of the QT interval is defined as the first deflection of the QRS complex. The end of the QT interval is defined as the intersection of the descending part of the T-wave (positive T-wave) with the isoelectric line.</offsets></p><p><offsets xml_i="5850" xml_f="6122" txt_i="3061" txt_f="3333"> If a U-wave appears immediately after the T-wave has returned to the baseline, the QT interval is measured as the nadir between T and U-waves. If it is not clear whether a second hump occurs before the T wave has returned to baseline, it is included in the QT interval. (</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="6152" xml_f="6160" txt_i="3333" txt_f="3341">Figure 1</offsets></xref><offsets xml_i="6167" xml_f="6168" txt_i="3341" txt_f="3342">)</offsets></p><p><offsets xml_i="6175" xml_f="6321" txt_i="3343" txt_f="3489">QT interval for research purpose is measured by vernier caliper, digitizing pad on the paper ECG as well as by on-screen calipers in digital ECGs.</offsets></p></sec><sec sec-type="" id="s3"><title><offsets xml_i="6363" xml_f="6377" txt_i="3491" txt_f="3505">Holter vs ECGs</offsets></title><p><offsets xml_i="6388" xml_f="6749" txt_i="3506" txt_f="3867">A continuous 12-lead Holter can be used as an alternative method for the standard digital 12-lead ECGs because of following reasons i) It provides the  continuous ambulatory  recording for 24 hours, thereby enabling  retrieval of the ECGs based on pharmacokinetic data and (ii)It provides useful data for cardiac arrthymias by continuous beat to beat analysis [</offsets><xref ref-type="bibr" rid="R4"><offsets xml_i="6780" xml_f="6781" txt_i="3867" txt_f="3868">4</offsets></xref><offsets xml_i="6788" xml_f="6906" txt_i="3868" txt_f="3986">]. However,12-lead Holter has many potential problems such as postural variation leading to change in ECG morphology [</offsets><xref ref-type="bibr" rid="R5"><offsets xml_i="6937" xml_f="6938" txt_i="3986" txt_f="3987">5</offsets></xref><offsets xml_i="6945" xml_f="6946" txt_i="3987" txt_f="3988">-</offsets><xref ref-type="bibr" rid="R7"><offsets xml_i="6977" xml_f="6978" txt_i="3988" txt_f="3989">7</offsets></xref><offsets xml_i="6985" xml_f="7025" txt_i="3989" txt_f="4029">] and multiple artifacts due to motion [</offsets><xref ref-type="bibr" rid="R8"><offsets xml_i="7056" xml_f="7057" txt_i="4029" txt_f="4030">8</offsets></xref><offsets xml_i="7064" xml_f="7279" txt_i="4030" txt_f="4245">]. Due to the change in position of the limb electrodes in the Holter recording, there is significant change in the QT interval measurement as it is measured in Lead II and Lead II comprises of limb lead electrodes.</offsets></p><p><offsets xml_i="7286" xml_f="7320" txt_i="4246" txt_f="4280">A study by Sarapa and colleagues [</offsets><xref ref-type="bibr" rid="R10"><offsets xml_i="7352" xml_f="7354" txt_i="4280" txt_f="4282">10</offsets></xref><offsets xml_i="7361" xml_f="7830" txt_i="4282" txt_f="4751">] reviewed the utility of Holter-derived 12-lead ECG and standard digital 12-lead ECG in detection of sotalol-induced QT prolongation in healthy volunteers. They reported a difference between standard digital ECG and Holter-derived 12 lead ECG of 5.2 ± 19 ms, They also reported a difference of -5 ± 70 ms in measurement of the RR interval. The reason for this difference is apparently related to the    technique of recording or measurement at the ECG core laboratory.</offsets></p></sec><sec sec-type="" id="s4"><title><offsets xml_i="7872" xml_f="7909" txt_i="4753" txt_f="4790"> Issues (fallacies of QT measurement)</offsets></title><sec id="s4a"><title><offsets xml_i="7938" xml_f="7946" txt_i="4791" txt_f="4799">Wide QRS</offsets></title><p><offsets xml_i="7957" xml_f="8286" txt_i="4800" txt_f="5129">The QT is less reliable when the QRS duration (QRSd) is ≥ 120 ms, as the increased QRSd which measures the duration of ventricular depolarization contributes to prolongation of the QT interval. The JT interval (defined as QT- QRSd) has been proposed as a more valid way to assess ventricular repolarization in such circumstances.</offsets></p><p><offsets xml_i="8293" xml_f="8308" txt_i="5130" txt_f="5145">Zhou SH et al [</offsets><xref ref-type="bibr" rid="R11"><offsets xml_i="8340" xml_f="8342" txt_i="5145" txt_f="5147">11</offsets></xref><offsets xml_i="8349" xml_f="9189" txt_i="5147" txt_f="5984">] examined the influence of QRS duration on the JT and QT intervals in 20,687 normal adult subjects and 2,865 subjects with various categories of intraventricular conduction delay (IVCD). Estimates for coefficients for multiple regression of QRS duration on QT and JT intervals combined with a correction term for heart rate (HR) were determined for each VCD category. QRS duration accounted for about 16% of total QT variation, but had a practically negligible effect on JT interval in complete bundle branch blocks. A single-parameter formula was derived for the JT prolongation index of the form JTI = JT (HR + 100)/518, with a JTI &gt; or = 112 identifying repolarization prolongation in all VCD categories. They concluded that it is preferable to use JT rather than QT as a more appropriate index of duration of repolarization in IVCD.</offsets></p><p><offsets xml_i="9196" xml_f="9203" txt_i="5985" txt_f="5992">Das G [</offsets><xref ref-type="bibr" rid="R12"><offsets xml_i="9235" xml_f="9237" txt_i="5992" txt_f="5994">12</offsets></xref><offsets xml_i="9244" xml_f="10416" txt_i="5994" txt_f="7166">] evaluated the relative contribution of the depolarization and the repolarization time prolongation to the prolonged QT interval in patients with (IVCD). The QRS, QT, and JT intervals were measured in 72 subjects with various types of IVCD. The observed intervals in IVCD subjects were compared to similar intervals in 33 healthy individuals in whom there was no evidence for intraventricular conduction abnormalities. The QTc (QT interval corrected for heart rate) in subjects with IVCD were 445 ± 6.8 msec (mean ± SEM) in those with LAD, 470 ± 9.1 msec with RBBB, and 489 ± 6.9 msec with LBBB. All of these intervals were significantly prolonged compared to 430 ± 4.3 msec in the control group. The prolongation of QTc interval in each category of IVCD subjects was entirely secondary to a prolonged depolarization time, as the JT intervals were not significantly different from those observed in the control group (F = 0.5, p = NS). These observations may provide an explanation for the differential prognosis for subjects with prolonged QT interval with prolonged repolarization time as compared to those with prolonged QT interval with prolonged depolarization time.</offsets></p><p><offsets xml_i="10423" xml_f="10572" txt_i="7167" txt_f="7316">Prolonged heart rate-corrected QT interval is associated with higher risk of mortality in patients with coronary heart disease (CHD). Crow RS et al [</offsets><xref ref-type="bibr" rid="R13"><offsets xml_i="10604" xml_f="10606" txt_i="7316" txt_f="7318">13</offsets></xref><offsets xml_i="10613" xml_f="10822" txt_i="7318" txt_f="7527">] assessed JT interval in these patients with CHD and QRSd  ≥ 120 ms. and concluded that the JTc is a simple measurement that is a significant independent predictor of  CHD events in men with wide QRS complex.</offsets></p></sec><sec id="s4b"><title><offsets xml_i="10853" xml_f="10861" txt_i="7529" txt_f="7537">Gender: </offsets></title><p><offsets xml_i="10872" xml_f="11076" txt_i="7538" txt_f="7742">Bazett’s formula (QTcB) has been more frequently used in the medical literature than Fridericia’s formula, so that most reported criteria for normal and abnormal values are derived from Bazett’s formula (</offsets><xref ref-type="table" rid="T1"><offsets xml_i="11108" xml_f="11115" txt_i="7742" txt_f="7749">Table 1</offsets></xref><offsets xml_i="11122" xml_f="11125" txt_i="7749" txt_f="7752">) [</offsets><xref ref-type="bibr" rid="R14"><offsets xml_i="11157" xml_f="11159" txt_i="7752" txt_f="7754">14</offsets></xref><offsets xml_i="11166" xml_f="11167" txt_i="7754" txt_f="7755">]</offsets></p></sec><sec id="s4c"><title><offsets xml_i="11198" xml_f="11225" txt_i="7757" txt_f="7784">Magnitude of QT variability</offsets></title><p><offsets xml_i="11236" xml_f="11706" txt_i="7785" txt_f="8255">Significant spontaneous variability is seen in the QT interval, and this may result in spurious QT prolongation and unnecessary concern about cardiac safety. To avoid this spurious variability, data on QT, QTc intervals should always be presented both as analyses of central tendency  (means, medians, ranges, etc.) and categorical analyses (proportion of individual subjects in each  treatment group experiencing specified degrees of abnormality i.e. outlier analyses).</offsets></p></sec></sec><sec sec-type="" id="s5"><title><offsets xml_i="11754" xml_f="11782" txt_i="8258" txt_f="8286">Analysis of central tendency</offsets></title><p><offsets xml_i="11793" xml_f="11870" txt_i="8287" txt_f="8364">For analyses of central tendency, the emphasis should be on following factors</offsets></p><sec id="s5a"><title><offsets xml_i="11895" xml_f="11935" txt_i="8365" txt_f="8405"> Maximum change in the QT, QTc Intervals</offsets></title><p><offsets xml_i="11946" xml_f="12293" txt_i="8406" txt_f="8753">The maximum observed difference  between on-treatment and baseline QT, QTc values should be expressed both as mean  and median changes in the population. This value is meaningful only as a comparison  with placebo or a non-QT prolonging drug, as selection of the highest of many on- treatment values will invariably show an increase from baseline.</offsets></p></sec><sec id="s5b"><title><offsets xml_i="12324" xml_f="12354" txt_i="8755" txt_f="8785">Time matched QT, QTc Intervals</offsets></title><p><offsets xml_i="12365" xml_f="12679" txt_i="8786" txt_f="9100">Mean changes from baseline in the observed QT, QTc interval can be presented as time-matched control and treatment group values. Time matched ECGs counter the circadian variation in the QT interval. Although these values may show regression to the mean, they do not have the same upward bias as the maximum change.</offsets></p></sec></sec><sec sec-type="" id="s6"><title><offsets xml_i="12727" xml_f="12747" txt_i="9103" txt_f="9123">Categorical analyses</offsets></title><p><offsets xml_i="12758" xml_f="13075" txt_i="9124" txt_f="9441">As the absence of statistically or clinically significant differences between the test drug and  comparator groups does not exclude the possibility of marked QT,QTc interval prolongation  occurring in individual subjects, analyses of central tendency should always be accompanied by  appropriate categorical analyses.</offsets></p><p><offsets xml_i="13082" xml_f="14109" txt_i="9442" txt_f="10469">Categorical analyses of QT, QTc interval data are based on the number and percentage of patients meeting or exceeding some predefined upper limit value. Clinically noteworthy signals may be defined in terms of absolute (readings in excess of some specified threshold value) QT, QTc intervals or changes from baseline control Although increases from baseline in the QT, QTc interval constitute signals of interest, interpretation of these differences is complicated by the potential for changes not related to drug therapy, including regression toward the mean and choice of extreme values. Regression toward the mean refers to the tendency of subjects with high baseline values to have lower values at later time points, while subjects with low baseline values tend to experience increases. The direction of regression depends on initial selection criteria; e.g., if subjects with high baseline QT, QTc interval values are excluded from the trial, values recorded during treatment will tend to rise relative to baseline levels.</offsets></p><p><offsets xml_i="14116" xml_f="14317" txt_i="10470" txt_f="10671">The process of choosing the highest of multiple observed values will also invariably cause an apparent change from any single baseline value, a phenomenon found in both drug and placebo-treated groups.</offsets></p><p><offsets xml_i="14324" xml_f="14753" txt_i="10672" txt_f="11101">To minimize the effect of spontaneous variability, we put forward the following recommendations: 1) To use trained readers2) To take on-screen measurements in an ECG core Lab 3) To compare with the results in the appropriate control group(s), including placebo or a drug with no QT, QTc prolongation effect 4) To compare with multiple baseline values with multiple, time-matched on-treatment values (not just the greatest value).</offsets></p></sec></body><back><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kautzener</surname><given-names>J</given-names></name></person-group><article-title>QT interval measurements</article-title><source>Card Electrophysiolol Rev</source><year>2002</year><volume>6</volume><fpage>273</fpage><lpage>277</lpage></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzara</surname><given-names>R</given-names></name></person-group><article-title>Antiarrhythmic drugs and torsade de pointes</article-title><source>Eur Heart J</source><year>1993</year><volume>14</volume><issue>suppl H</issue><fpage>88</fpage><pub-id pub-id-type="pmid">8293758</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassimoto</surname><given-names>Masatoshi, DVM</given-names></name></person-group><article-title>Accurate Evaluation of QT Interval in conscious Rhesus Monkeys by use of Holter ECG</article-title><source>J of Electro cardiology</source><year>2002</year><volume>35</volume><fpage>333</fpage><lpage>342</lpage></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denes</surname><given-names>P</given-names></name></person-group><article-title>The importance of derived 12-lead Electrocardiography in the Interpretation of Arrhythmias detected by Holter recording</article-title><source>Am Heart J</source><year>1992</year><volume>124</volume><fpage>905</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">1382387</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowey</surname><given-names>KR</given-names></name><name><surname>Kocovic</surname><given-names>DZ</given-names></name></person-group><article-title>Ambulatory Electrocardiographic Recording</article-title><source>Circulation</source><year>2003</year><volume>108</volume><fpage>e31</fpage><lpage>e33</lpage><pub-id pub-id-type="pmid">12900497</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>J</given-names></name><name><surname>Sahakian</surname><given-names>AV</given-names></name><name><surname>Swiryn</surname><given-names>S</given-names></name></person-group><article-title>Accelerometer-based Body- position sensing for     Ambulatory Electrocardiographic Monitoring</article-title><source>Biomed Instrum Technol</source><year>2003</year><volume>37</volume><fpage>338</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">14564805</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiner</surname><given-names>Z</given-names></name><name><surname>Baharav</surname><given-names>A</given-names></name><name><surname>Akselrod</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Detection of different Recumbent Body positions from the Electrocardiogram</article-title><source>Med Biol Eng Comput</source><year>2003</year><volume>41</volume><fpage>206</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">12691442</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>AY</given-names></name><name><surname>Kam</surname><given-names>C</given-names></name><name><surname>Lai</surname><given-names>KW</given-names></name><etal></etal></person-group><article-title>Changes in Heart rate and R-wave Amplitude with Posture</article-title><source>Chin J Physiol</source><year>2003</year><volume>46</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">12974297</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bethge</surname><given-names>KP</given-names></name><name><surname>Gonska</surname><given-names>BD</given-names></name></person-group><article-title>Long-term electrocardiography: value and reliability of various systems</article-title><source>Z Kardiol</source><year>1985</year><volume>74</volume><fpage>567</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">2416139</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarapa</surname><given-names>N</given-names></name><name><surname>Morganroth</surname><given-names>J</given-names></name><name><surname>Couderc</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods</article-title><source>Ann Noninvasive Electrocardiol</source><year>2004</year><volume>9</volume><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">14731216</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>SH</given-names></name><name><surname>Wong</surname><given-names>S</given-names></name><name><surname>Rautaharju</surname><given-names>PM</given-names></name><etal></etal></person-group><article-title>Should the JT rather than the QT interval be used to Detect Prolongation of Ventricular Repolarization? An Assessment in Normal Conduction and in Ventricular Conduction Defects</article-title><source>J Electrocardiol</source><year>1992</year><volume>25</volume><issue>Suppl</issue><fpage>131</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">1297679</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>G</given-names></name></person-group><article-title>QT interval and Repolarization Time in Patients with Intraventricular Conduction Delay</article-title><source>J Electrocardiol</source><year>1990</year><volume>23</volume><fpage>49</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">2406360</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname><given-names>RS</given-names></name><name><surname>Hannan</surname><given-names>PJ</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name></person-group><article-title>Prognostic Significance of Corrected QT and corrected JT interval for incident Coronary Heart Disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up</article-title><source>Circulation</source><year>2003</year><volume>108</volume><fpage>1985</fpage><lpage>1989</lpage><pub-id pub-id-type="pmid">14517173</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>AJ</given-names></name></person-group><article-title>The QT interval and torsade de pointes</article-title><source>Drug Safety</source><year>1999</year><volume>21</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">10597863</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><table frame="hsides" rules="groups" border="5"><tr><th colspan="1" rowspan="2" align="center">Rating</th><th colspan="2" rowspan="1" align="center">QTcB in msec</th></tr><tr><td align="center" rowspan="1" colspan="1">Adult Males</td><td align="center" rowspan="1" colspan="1">Adult Females</td></tr><tr><td rowspan="1" colspan="1">Normal</td><td align="center" rowspan="1" colspan="1">&lt; 430</td><td align="center" rowspan="1" colspan="1">&lt; 450</td></tr><tr><td rowspan="1" colspan="1">Borderline</td><td align="center" rowspan="1" colspan="1">430-450</td><td align="center" rowspan="1" colspan="1"> 450-470</td></tr><tr><td rowspan="1" colspan="1">Prolonged</td><td align="center" rowspan="1" colspan="1">&gt; 430</td><td align="center" rowspan="1" colspan="1">&gt; 450</td></tr></table></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Schematic diagram showing QT interval. Three morphologic forms of TU complexes. Arrows indicate the end of QT interval measured excluding the second hump; vertical lines indicate the end of QT interval measured including the second hump.</p></caption><graphic xlink:href="ipej040156-01"></graphic></fig></floats-group></article>